MEF2C has reported roles in numerous age-related conditions, including Alzheimer’s disease (Xue et al., 2021) and muscle wasting in cancer (Judge et al., 2020) and GRM is associated with age-related hearing loss (Liu et al., 2021b). This evidence concerns the gene MEF2C and early-onset autosomal dominant Alzheimer disease.